GLP-1 medication access online for Bennington, Vermont
Company statements checked between September 13, 2026 and September 23, 2026: 3 covered companies — Gentle Health, GoodRx Care and OrderlyMeds — advertise online GLP-1 medication access for patients in Vermont, including Bennington. Confirm eligibility and total charges with the provider.
Browse online GLP-1 medication access programs advertised for patients in Bennington, Vermont, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded oral semaglutide · Compounded injectable semaglutide · Compounded injectable tirzepatide | $112/mo advertised monthly bundle, Compounded oral semaglutide | Official site ↗ | |
| GoodRx Care | Wegovy pen · Wegovy HD · Wegovy tablet · Zepbound KwikPen | $188/mo partial monthly subtotal, Wegovy tablet | Official site ↗ | |
| OrderlyMeds | Wegovy · Zepbound | $1,498/mo advertised monthly bundle, Zepbound | Official site ↗ |
Health context in Bennington
GLP-1 medication access programs are marketed for weight management and, for some products, type 2 diabetes. These Bennington figures give local context only. Among the 5 Vermont cities in this research set, Bennington has the lowest estimate for routine checkup in the past year among adults (72.8%).
| Measure | Bennington | 95% range | Among the 5 Vermont cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 31.6% | 26.8–36.7% | second-highest | 2023 |
| Diagnosed diabetes among adults | 7.6% | 6.5–8.9% | second-highest | 2023 |
| High blood pressure among adults | 28.8% | 25.8–31.9% | second-highest | 2023 |
| Lack of health insurance among adults aged 18–64 | 7.2% | 5.5–9.2% | second-highest | 2023 |
| Routine checkup in the past year among adults | 72.8% | 69–76.1% | lowest | 2023 |
Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 8,795); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
This GLP-1 medication access page is the Bennington entry point to the Vermont statewide online listing, not evidence of an office, pharmacy or clinician in Bennington. Each company below appears because its named products have their own Vermont evidence; the heading does not extend coverage to every medicine in the category, and branded and compounded products are listed separately.
Use the Vermont guide to compare the listed programs, their separate prices and their billing and cancellation terms before choosing which offer to ask a company about.
These are online services advertised for patients in Vermont, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Bennington, and a listing is not a prescription, appointment or coverage guarantee. Read the Vermont GLP-1 medication access guide for product details, charges and limitations.
Selected providers
Gentle Health
Gentle Health's separately priced compounded oral semaglutide, injectable semaglutide and injectable tirzepatide programs, if prescribed.
Compounded oral semaglutide (oral): 2–4 mg/day — $112/mo · >4–8 mg/day — $189/mo · >8–12 mg/day — $258/mo
Compounded injectable semaglutide (injection): 0.24–0.48 mg/wk — $135/mo · >0.48–1.2 mg/wk — $159/mo · >1.2–2.4 mg/wk — $199/mo
Compounded injectable tirzepatide (injection): 2.5–5 mg/wk — $169/mo · >5–10 mg/wk — $219/mo · >10–15 mg/wk — $269/mo
- Compounded oral semaglutide — oral: state evidence checked · Availability source · Full evidence notes
- Compounded injectable semaglutide — injection: state evidence checked · Availability source · Full evidence notes
- Compounded injectable tirzepatide — injection: state evidence checked · Availability source · Full evidence notes
Official provider website · Product and access details
Medical Director: James Simmons, MD — company-reported; see profile for the source.
GoodRx Care
GoodRx Care Direct, a cash-pay membership through which GoodRx advertises separately priced branded semaglutide and tirzepatide products.
Wegovy pen (pen): 0.25 or 0.5 mg, first two fills — $238/mo · after the first two fills — $388/mo
Wegovy HD (pen): 7.2 mg — $438/mo
Wegovy tablet (oral tablet): 1.5 mg — $188/mo · 4 mg — $238/mo · higher doses, from — $338/mo
Zepbound KwikPen (pen): introductory KwikPen strength (page labels it 10 mg) — $338/mo
- Wegovy pen — pen: state evidence checked · Availability source · Full evidence notes
- Wegovy HD — pen: state evidence checked · Availability source · Full evidence notes
- Wegovy tablet — oral tablet: state evidence checked · Availability source · Full evidence notes
- Zepbound KwikPen — pen: state evidence checked · Availability source · Full evidence notes
OrderlyMeds
OrderlyMeds branded Wegovy and Zepbound injection plans, each priced separately.
Wegovy (pen): .25mg, .5mg and 1mg (listed doses) — $1,839/mo
Zepbound (pen): 2.5 mg to 15 mg (advertised range) — $1,498/mo
- Wegovy — pen: state evidence checked · Availability source · Full evidence notes
- Zepbound — pen: state evidence checked · Availability source · Full evidence notes
More listings
Other medications for Bennington: Semaglutide · Tirzepatide
GLP-1 medication access in other Vermont cities: Burlington · Essex Junction · Rutland · South Burlington
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.